Biomedical Technology Research

Paper Summary:

The paper argues that restraints on areas such as embryo research have produced a devastating impact on the expansion of the biomedical technologies involved with regenerative medicine. The paper considers the ethical issues involved and posits that while there must certainly be a level of restraint in dealing with the possible misuse of these new inventions, it must not be so restrictive as to limit any room for advancements in the field. The paper asserts that there must be some middle ground upon which both sides of the issue can agree that the wonders of this field are for the benefit of humanity and not its destruction.

From the Paper:

"The field of Biomedical Technology has been growing by leaps and over the past half-century. At the beginning of that time many research scientists and their funding corporations were starting to realize the amazing potential of this field for both for humanitarian and commercial use. The advances alone in the use of recombinant DNA techniques as well as that of cell fusion and other advances in were revealing tremendous potential regarding their impact on the health, life and the longevity of human beings. (Blackford, 2006, p. 526) Biomedical technology has become a tremendous boon to mankind creating completely new approaches in the treatment of diseases and the consequent extension of life expectancy than had never been imagined previously. In our lifetime we have certainly seen the immediate effect of this in fact; evident in such advances that have enabled paramedics and doctors to artificially maintain the body's critical functions in emergency situations that would have otherwise resulted in immediate death ("Death," 2007)."

Sample of Sources Used:

• Andreasen, N. C. (2003). Brave New Brain: Conquering Mental Illness in the Era of the Genome. New York: Oxford University Press.
• Blackford, R. (2006). Dr. Frankenstein Meets Lord Devlin: Genetic Engineering and the Principle of Intangible Harm. The Monist, 89(4), 526
• Collins, S. W. (2004). The Race to Commercialize Biotechnology: Molecules, Markets, and the State in the United States and Japan. New York: RoutledgeCurzon.
• Death. (2007). In The Columbia Encyclopedia (6th ed.). New York: Columbia University Press.
• Dunn, K. (2002, June). Cloning Trevor; Granted Rare Access to the Labs of Advanced Cell Technology, the Only U.S. Group Openly Pursuing Human Cloning Research for Medical Purposes Our Correspondent Spent Six Months Tracking Highly Experimental Work on the Cells of a Young Boy with a Life-Threatening Genetic Disorder. The Atlantic Monthly, 289, 31+.

More papers on Biomedical Technology Research:

• Argumentative Essay # 62440 : "Stem Cell Research"
• Research Paper # 61444 : "Science and Technology in Animal Rights Literature"
• Essay # 14681 : "Biomedical Ethics"

APA Citation:

MLA Citation: